Byun Joung Hun, Kim Tae Gyu, Song Yun Gyu
Department of Thoracic and Cardiovascular Surgery, Gyeongsang National University Changwon Hospital.
Department of Radiation Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine.
Korean J Thorac Cardiovasc Surg. 2017 Oct;50(5):371-377. doi: 10.5090/kjtcs.2017.50.5.371. Epub 2017 Oct 5.
Lesions in distal target arteries hinder surgical bypass procedures in patients with peripheral arterial occlusive disease.
Between April 2012 and October 2015, 16 patients (18 limbs) with lifestyle-limiting claudication (n=12) or chronic critical limb ischemia (n=6) underwent femoral-above-knee (AK) polytetrafluoroethylene (PTFE) bypass grafts with a bridging stent graft placement between the distal target popliteal artery and the PTFE graft. Ring-supported PTFE grafts were used in all patients with no available vein for graft material. Follow-up evaluations assessed clinical symptoms, the ankle-brachial index, ultrasonographic imaging and/or computed tomography angiography, the primary patency rate, and complications.
All procedures were successful. The mean follow-up was 12.6 months (range, 11 to 14 months), and there were no major complications. The median baseline ankle-brachial index of 0.4 (range, 0.2 to 0.55) significantly increased to 0.8 (range, 0.5 to 1.0) at 12 months (p<0.01). The primary patency rate at 12 months was 83.3%. The presenting symptoms resolved within 2 weeks.
In AK bypasses with a diffusely diseased distal target popliteal artery or when below-knee (BK) bypass surgery is impossible, this procedure could be clinically effective and safe when used as an alternative to femoral-BK bypass surgery.
远端靶动脉病变会妨碍外周动脉闭塞性疾病患者的外科搭桥手术。
在2012年4月至2015年10月期间,16例(18条肢体)有生活受限型间歇性跛行(n = 12)或慢性严重肢体缺血(n = 6)的患者接受了股-膝上(AK)聚四氟乙烯(PTFE)搭桥移植术,并在远端靶腘动脉和PTFE移植物之间放置了桥接支架移植物。所有患者均使用了环形支撑的PTFE移植物,因为没有可用的静脉作为移植物材料。随访评估包括临床症状、踝肱指数、超声成像和/或计算机断层血管造影、原发性通畅率及并发症。
所有手术均成功。平均随访时间为12.6个月(范围11至14个月),无重大并发症。基线踝肱指数中位数为0.4(范围0.2至0.55),在12个月时显著增至0.8(范围0.5至1.0)(p<0.01)。12个月时原发性通畅率为83.3%。出现的症状在2周内缓解。
在远端靶腘动脉弥漫性病变的AK搭桥手术中,或在膝下(BK)搭桥手术无法进行时,作为股-BK搭桥手术的替代方法,该手术在临床应用中可能是有效且安全的。